Plus Therapeutics, Inc.
PSTVNASDAQHealthcareBiotechnology
As of Aug 7, 2026 close
- Market cap
- $26.48M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.46$15.33
- Volume (live)
- -
- Avg. volume (3M)
- 67.47K
Plus Therapeutics (PSTV) Stock Price & Financial Analysis
Plus Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.77 - $3.96 |
|---|---|
| 52-Week High | $15.33 |
| 52-Week Low | $0.46 |
| Open | $3.78 |
| Volume (last close) | 67.47K |
| Average Volume (3M) | 67.47K |
| Revenue (TTM) | 5.18M |
|---|---|
| Net Income (TTM) | -26.09M |
| Free Cash Flow (TTM) | -23.55M |
| EPS (TTM) | −$4.98 |
| Profit Margin | -503.43% |
| Operating Margin | -509.46% |
| Return on Equity (ROE) | -477.54% |
| Debt to Equity | 0.13 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 26.48M |
|---|---|
| Shares Outstanding | 6.90M |
| Price to Sales (P/S) | 5.11 |
| Price to Book (P/B) | 4.85 |
| EV/EBITDA | -1.11 |
| 50-Day MA | $4.38 |
|---|---|
| 200-Day MA | $4.67 |
| 1-Year Change | +504.60% |
Source: Market prices and company fundamentals. Data as of Aug 7, 2026. Data sources and methodology
Plus Therapeutics at a Glance
As of the Aug 7, 2026 close, Plus Therapeutics (PSTV) has a market capitalization of $26.48M. The stock trades at 5.1× sales. Over the trailing twelve months it lost $26.09M on revenue of $5.18M and burned $23.55M of free cash flow. Revenue fell 0.5% year over year.
As of its latest reported balance sheet, it holds $2.37M in cash and securities against $725.00K of debt, a net cash position of $1.64M.
Plus Therapeutics does not currently pay a dividend.
The share price is up 504.6% over the past year. At $3.84 (the Aug 7, 2026 close) it sits within its 52-week range of $0.46 to $15.32, below its 200-day moving average of $4.67.
Frequently Asked Questions About Plus Therapeutics
What is the current stock price for PSTV?
As of the Aug 7, 2026 close, PSTV stock trades at $3.84. The 52-week range is $0.46–$15.33, with a day range of $3.77–$3.96.
What is the P/E ratio for PSTV?
The P/E ratio (Price-to-Earnings) for PSTV is shown in the Key Statistics section. This valuation metric helps compare Plus Therapeutics, Inc. to industry peers.
Does PSTV pay dividends?
Plus Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PSTV?
Analyst ratings and recommendations for PSTV are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PSTV?
As of the Aug 7, 2026 close, Plus Therapeutics's market capitalization is $26.5M, classifying it as a micro-cap company. Plus Therapeutics operates in the Healthcare sector within the Biotechnology industry.